Tufts Center for the Study of Drug Development

Optimizing DCT Solutions: The Road Ahead: Understanding how to continuously improve DCT methods for patient convenience, retention, and ease of participation. Collecting actionable data and addressing challenges to optimize these innovative solutions. Access the panel discussion recording from the Decentralized Trials & Research Alliance (DTRA) Annual 2024 Meeting in November moderated by Brandon Maggio of GSK, with industry experts Zachary Smith (Tufts CSDD), Christoph Hornik (Duke Clinical Research Institute), and Dr. Timil Patel (FDA). 🔗 https://lnkd.in/eQUR4fzJ #DecentralizedTrials #PatientAccess #ClinicalResearch #DCT

As we wrap up the 2025 Postgraduate Course in Clinical Trials and Drug Development, we want to extend a heartfelt thank you to all of our participants, faculty, and facilitators who made this year's course an incredible success! This year’s cohort brought passion, dedication, and a commitment to advancing the field of clinical research. We are proud to have hosted such a dynamic group of professionals eager to learn, collaborate, and drive innovation in the world of drug development and clinical trials. 🚀 A special thank you to our expert faculty, whose knowledge and insights inspired meaningful discussions and provided invaluable learning experiences throughout the course. Your contributions are deeply appreciated, and we are grateful for your continued support of the Tufts CSDD mission. Congratulations to the 2025 cohort, and thank you once again to everyone who made this year’s program such a success. Course Facilitators: Sarah Wrobel, MHA Course Operations, Marketing & Promotion Strategist: Ava Feuer Program Slide Support: Hana D. Course Moderators: Kenneth I Kaitin, Ken Getz, Lindsay McNair, Course Faculty: Varun Garg | Orest Hurko, | Chris Albani | Kevin Bugin | Lawrence Liberti | Nancy Smerkanich | Sue Fish | Zeid Barakat | Samir Shah | Mary Jo Lamberti | Gorana Capkun | Peter Neumann #TuftsCSDD #ClinicalTrials #DrugDevelopment #PostgraduateCourse 

We recently had the privilege of collaborating with a local pharmaceutical company to deliver an in-depth, live professional development course on the complexities of drug development. Over the course of three months, 28 colleagues gathered bi-weekly to explore everything from bench to bedside, led by Tufts CSDD Senior Fellow Robert Franco, PhD, and Operations & Development Manager Sarah Wrobel, MHA. This immersive program empowered participants with the skills and knowledge to navigate the dynamic & fast-paced biopharmaceutical landscape.    Interested in learning more about our tailored professional development programs? Reach out to Sarah Wrobel, MHA, at sarah.wrobel@tufts.edu   #DrugDevelopment  #PharmaExcellence  #ProfessionalGrowth    Yun Wang | Harper Lee Kaye | Varun Garg | Lindsay McNair, MD, MPH, MSB | Jerald S. Schindler, Zeid Barakat | Christine Carberry | Chris Albani

Where do you fall along the maturity curve of DCT solutions? Are you: * Beginning to explore decentralized clinical trial (DCT) approaches? * Implementing DCT components with a structured strategy? * Advancing to a maturity level where decentralized approaches are comprehensively embraced? * Leading the way and pioneering DCT practices while setting industry standards? The PACT Consortium offers an opportunity to collaborate with diverse stakeholders across all maturity levels to revolutionize clinical trials. Join the PACT Consortium today to share your insights and help drive innovation. Visit https://lnkd.in/ehsWfC-h today or connect with Joan Chambers.

Pharmaceutical R&D is becoming more complex, but the opportunities for transformation are growing too. The Tufts CSDD Circle of Supporters brings thought leaders together to tackle R&D’s toughest challenges and advance our mission to deliver trusted, data-driven insights worldwide. Discover the benefits of membership. Visit https://lnkd.in/ecU4iKrP or connect with Joan Chambers.

Insights identify opportunities to optimize sponsor, CRO, and site collaborations🖊️Beth Harper, Project Manager, Senior Research Consultant;Zachary Smith, Assistant Director, Data Sciences and Analytics; Ruby Ford, MPH Ruby Madison Ford, Research Analyst; and Ken Getz, Executive Director and Professor; all with Tufts Center for the Study of Drug Development

Measuring Impact of DCT Methods: A New Era in Clinical Trials Diving into how decentralized clinical trials (DCT) are revolutionizing patient enrollment and increasing access for diverse communities. With strategic tactics, key KPIs, and real-time data, the impact is clear. Access the panel discussion recording from the DTRA Annual 2024 Meeting in November moderated by Brandon Maggio of GSK, with industry experts Zachary Smith (Tufts CSDD), Christoph Hornik (Duke Clinical Research Institute), and Dr. Timil Patel (FDA). 🔗 https://lnkd.in/eQUR4fzJ #DCT #ClinicalTrials #HealthcareInnovation 

Are you looking for original research, analysis, and insight into critical drug development issues and the clinical trials landscape? The Tufts CSDD bi-monthly publication provides all this cutting-edge information to help you stay informed about ongoing industry trends. Start your annual subscription today. Multi-reader programs are also available. Visit https://lnkd.in/dSYX898E or contact Joan Chambers at joan.chambers@tufts.edu 

DCT solutions offer opportunities to reduce participant burden, improve patient access, increase participation from underrepresented groups, and enhance convenience for patients, caregivers, and families. PACT Consortium member organizations collaborate to gather robust evidence on the use of DCTs, examine specific elements in greater depth, and explore much more. Join this digital transformation by becoming a member of the PACT Consortium. Visit https://lnkd.in/ehsWfC-h today or connect with Joan Chambers. #DCT #ClinicalTrials #Patients #DigitalHealth #Diversity

From groundbreaking studies on AI in drug development to in-depth analyses of clinical trial efficiency, it’s been a month of dynamic research and vibrant discussions. We're proud to see our work sparking conversations across LinkedIn, the media, and the industry. Stay connected with us as we continue exploring patient participation, risk-based monitoring, and strategies to enhance clinical trial outcomes. 💡 Ready to collaborate or learn more? Visit our website or reach out directly. Let’s shape the future of drug development together: https://csdd.tufts.edu/ #TuftsCSDD #ClinicalResearch #DrugDevelopment #Innovation